These days you just have to wonder about the greed and corruption that is going on all around. Senator Dick Blumenthal is one of many who’ve been pointing out the naked corruption in the Trump family–Qatari jets, memecoins, Trump’s son being on the board of so many defence and prediction market companies you can’t keep…
Experts discuss how the expiration of ACA provisions and Medicaid cuts are leading to a surge in uninsured residents
Recent updates to the HIPAA Security Rule shift from addressable to mandatory requirements
Hemab Therapeutics and Seaport Therapeutics are the newest biotech companies to join the public markets, each with an upsized IPO. According to IPO research firm Renaissance Capital, April was the biggest month for biotech IPO proceeds in more than five years. The post Four Biotech IPOs Raise $1.5B in April, the Biggest Month in Five…
A Massachusetts regulator is warning that CVS and Mass General Brigham’s proposed MinuteClinic partnership could drive up healthcare spending by at least $40 million annually, largely through steering patients into a higher-priced system. Experts said the deal might improve convenience for some patients but is unlikely to meaningfully expand access — and could ultimately strengthen…
Building a medical practice that’s truly resilient can feel like pushing a rock up a hill. However, physicians who are ready, willing and able to stay adaptable and seize opportunities will give their medical practices staying power. The post The Evolving Medical Practice: How Doctors Can Adapt and Prosper In a Changing Environment appeared first…
Why targeted diversification across therapeutic areas will serve stakeholders and patients better The post The Biosimilar Market Isn’t Failing, It’s Finding Its Purpose appeared first on MedCity News.
While AI makes VC faster, it’s not necessarily wiser. In healthcare, where breakthroughs rarely resemble anything the market has seen before, that distinction is everything. The post The AI Funding Divide: Why VCs Will Miss the Next Healthcare Category Kings (And Where CEOs Should Look Instead) appeared first on MedCity News.
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed the results of the FDA’s largest baby formula safety test on CBS News 24/7’s The Daily Report on April 29. She also discussed how women seeking treatment for menopause symptoms are facing a shortage of estrogen patches on CBS News’ CBS Mornings on April 27….
One of the central tensions in pharmaceutical policy is the gap between what a drug is worth and what it actually costs. In theory, a drug’s price should reflect its value — its ability to improve health outcomes relative to the next best alternative. In practice, list prices are set by manufacturers, net prices are shaped by opaque…